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Condensation 1 
Cerebroplacental ratio is a marker of impaired fetal growth velocity and adverse 2 
pregnancy outcome, even in fetuses whose size is considered appropriate for gestational 3 
age. 4 
 5 
Short Title: Cerebroplacental ratio and fetal growth 6 
7 
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TWEETABLE ABSTRACT 1 
Cerebroplacental ratio is a marker of impaired fetal growth and adverse outcome, even 2 
in appropriately-sized fetuses.  3 
 4 
A brief statement about what is known 5 
Adding the assessment of fetal growth velocity to fetal size improves the prediction of 6 
perinatal morbidity in small for gestational age babies. Low cerebroplacental ratio is 7 
associated with adverse perinatal outcomes.  8 
 9 
A brief statement about what the study adds 10 
Even when corrected for fetal size and growth velocity, low cerebroplacental ratio 11 
remains significantly associated with operative delivery for fetal compromise. This 12 
suggests that cerebroplacental ratio is a potentially useful tool for the identification of at 13 
risk fetuses.  14 
 15 
Why do you think that your study should be published in a general 16 
obstetrics/gynecology Journal, such as AJOG, rather than in a subspecialty 17 
Journal? 18 
Fetal growth restriction, and the decisions around how to assess and when to deliver 19 
small for gestational age and growth restricted fetuses, are dilemmas faced by all 20 
practising obstetricians. This paper demonstrates how the cerebroplacental ratio could 21 
help clinicians distinguish growth restricted fetuses from those that are simply 22 
constitutionally small, and to identify those at risk of adverse perinatal outcome.   23 
 24 
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A summary in lay terms 1 
It has long been recognised that babies that are small for their gestation are at 2 
increased risk of complications around the time of birth, such as instrumental 3 
(forceps/vacuum) delivery or cesarean section for ‘fetal distress’, poor condition at birth, 4 
and admission to the neonatal unit. However, it is increasingly recognised that it is 5 
important to differentiate those babies that are not growing well (that is, failing to reach 6 
their growth potential) and therefore at increased risk, from those that are simply 7 
constitutionally small but growing normally, and who are therefore unlikely to be at 8 
increased risk. 9 
 10 
Fetuses that are failing to grow normally send more blood (and oxygen) to the brain and 11 
less to their lower extremities. This ‘redistribution’ of resources to the most critical 12 
organs at the expense of the less important can be assessed by comparing the blood 13 
flow in two fetal arteries – the cerebroplacental ratio (CPR). The lower the CPR, the 14 
greater the redistribution of blood and therefore, by implication, the greater the degree 15 
of compromise of and risk to the fetus. 16 
 17 
This large study of almost 8,000 pregnancies examined the relationship between the 18 
CPR, slowing of the growth of the baby’s abdomen, and complications around the time 19 
of birth. It found that low CPR was associated with several poor outcomes, including 20 
operative delivery for fetal distress and admission to the neonatal unit. Interestingly, 21 
being small (adjusted for gestation) was not associated with the risk of operative 22 
delivery for fetal distress whereas low CPR measured before birth was. This shows that 23 
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even babies considered to be of ‘normal’ size may not have been growing normally and 1 
may be at risk around the time of birth, while some small babies may have been 2 
growing normally and are not at risk. The implication is that, compared to the baby’s 3 
size, CPR measured before birth may be a better indicator of babies at risk of 4 
complications around the time of birth. 5 
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ABSTRACT 1 
Background: The cerebroplacental ratio has been proposed as a marker of failure to 2 
reach growth potential near term. Low cerebroplacental ratio, regardless of the fetal 3 
size, is independently associated with the need for operative delivery for presumed fetal 4 
compromise and with neonatal unit admission at term. 5 
Objective: The main aim of this study was to evaluate whether the cerebroplacental 6 
ratio at term is a marker of reduced fetal growth rate. The secondary aim was to 7 
investigate the relationship between low cerebroplacental ratio at term, reduced fetal 8 
growth velocity and adverse pregnancy outcome.  9 
Design: retrospective cohort study of singleton pregnancies in a tertiary referral center. 10 
The abdominal circumference was measured at 20-24 weeks’ gestation, and both 11 
abdominal circumference and fetal Dopplers recorded at or beyond 35 weeks, within 12 
two weeks of delivery. Abdominal circumference and birthweight values were converted 13 
into Z scores and centiles, respectively, and fetal Doppler parameters into multiples of 14 
median, adjusting for gestational age. Abdominal circumference growth velocity was 15 
quantified using the difference in abdominal circumference Z score, comparing the scan 16 
at or beyond 35 weeks with the scan at 20-24 weeks. Both univariable and multivariable 17 
logistic regression analyses were performed to investigate the association between low 18 
cerebroplacental ratio, low abdominal circumference growth velocity (in the lowest 19 
decile), and to identify and adjust for potential confounders. As a sensitivity analysis, we 20 
refitted the model excluding the data on pregnancies with small for gestational age 21 
neonates.  22 
Results: The study included 7944 pregnancies. Low cerebroplacental ratio multiples of 23 
median was significantly associated with both low abdominal circumference growth 24 
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velocity (adjusted OR 2.10; 95%CI 1.71-2.57, p<0.001) and small for gestational age 1 
(adjusted OR 3.60; 95%CI 3.04-4.25, p<0.001). After the exclusion of pregnancies 2 
resulting in small for gestational age neonates, low cerebroplacental ratio multiples of 3 
median remained significantly associated with both low abdominal circumference 4 
growth velocity (adjusted OR 1.76; 95%CI 1.34-2.30, p<0.001) and birthweight centile 5 
(adjusted OR 0.99; 95%CI 0.998-0.995, p<0.001). The need for operative delivery for 6 
fetal compromise was significantly associated with low cerebroplacental ratio (adjusted 7 
OR 1.40; 95%CI 1.10-1.78, p=0.006), even after adjusting for both the umbilical artery 8 
pulsatility index multiples of median and middle cerebral artery pulsatility index multiples 9 
of median. The results were similar even after the exclusion of pregnancies resulting in 10 
small for gestational age neonates (adjusted OR 1.39; 95%CI 1.06-1.84, p=0.018). Low 11 
cerebroplacental ratio multiples of median remained significantly associated with the 12 
risk of operative delivery for presumed fetal compromise (p<0.001), even after adjusting 13 
for the known antenatal and intrapartum risk factors. These associations persisted even 14 
after exclusion of small for gestational age births. In appropriate for gestational age 15 
sized fetuses, abdominal circumference growth velocity was significantly lower in those 16 
with low cerebroplacental ratio multiples of median than in those with normal 17 
cerebroplacental ratio multiples of median (p<0.001). 18 
Conclusion: Cerebroplacental ratio is a marker of impaired fetal growth velocity and 19 
adverse pregnancy outcome, even in fetuses whose size is considered appropriate 20 
using conventional biometry. 21 
 22 
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Keywords 1 
Abdominal circumference; lowest decile; adverse pregnancy outcome; birthweight; 2 
cerebroplacental ratio; fetal growth restriction; growth velocity; impaired; second 3 
trimester; small for gestational age; third trimester.  4 
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INTRODUCTION 1 
Fetal growth restriction is a major determinant of perinatal mortality and morbidity, in 2 
particular stillbirth, neonatal death, hypoxic ischemic encephalopathy and cerebral 3 
palsy.1-4 Despite the fact that small for gestational age (SGA), defined as fetal/birth 4 
weight below the 10th centile for that gestation, is considered a proxy for fetal growth 5 
restriction, in reality the majority of SGA fetuses are not growth restricted and do not 6 
experience an adverse pregnancy outcome.5 In order to assess fetal growth velocity, or 7 
growth restriction, an interval growth between two time points must be used to identify 8 
those fetuses deviating from their expected growth trajectory. Combined analysis of the 9 
fetal biometry in the third trimester and fetal growth velocity could identify the subset of 10 
SGA fetuses that are growth restricted and therefore at increased risk of neonatal 11 
morbidity.6 A recent screening study reported that the combination of an estimated fetal 12 
weight below the 10th centile and abdominal circumference (AC) growth velocity in the 13 
lowest decile is associated with a relative risk (RR) of delivering an SGA infant with 14 
neonatal morbidity of 17.6;6 this compares with an equivalent RR of 7.3 for fetuses with 15 
an estimated fetal weight below the 10th centile but normal AC growth velocity. A similar 16 
observation was reported in older studies, where the fetal growth velocity was slower in 17 
those that required operative delivery for fetal distress and in those requiring admission 18 
to the neonatal unit.7  19 
Impaired fetal growth velocity, defined as arrest of growth or a shift in its rate measured 20 
longitudinally at least twice 3 weeks apart, can be used as a surrogate marker of growth 21 
restriction.8 However, the assessment of serial fetal biometry is controversial for a 22 
number of reasons: firstly, absence of robust evidence that serial assessment would 23 
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improve the pregnancy outcome compared to cross sectional measurement; secondly, 1 
lack of agreed reference or standard to use; thirdly, lack of agreed gestational age at 2 
which fetal biometry should be measured; fourthly, lack of standardization which fetal 3 
biometry measure (e.g. AC) to use, and finally, the threshold to diagnose abnormal fetal 4 
growth is yet to be established.9-17  5 
Interestingly, in fetuses with suspected growth restriction and abnormal umbilical artery 6 
Doppler, reduced fetal growth rate is strongly associated with an abnormal 7 
cerebroplacental ratio (CPR).18 In contrast, if the CPR is normal, even in the setting 8 
of abnormal umbilical artery Doppler findings, fetuses grow at a rate similar to that of 9 
fetuses with normal umbilical artery findings.18 CPR is emerging as a marker of failure to 10 
reach growth potential near term. We have reported that lower fetal CPR, regardless of 11 
the fetal size, was independently associated with the need for operative delivery for 12 
presumed fetal compromise and with neonatal unit admission at term.19,20 If CPR is truly 13 
a marker of failure to reach growth potential, it would be expected to reflect impaired 14 
fetal growth velocity. The main aim of this study was to evaluate whether the CPR at 15 
term is a marker of reduced fetal growth rate. The secondary aim was to investigate the 16 
relationship between low CPR at term, reduced fetal growth velocity and adverse 17 
pregnancy outcome. 18 
 19 
MATERIALS AND METHODS 20 
This was a retrospective cohort study in a tertiary referral center over a 14-year period 21 
from 2000 to 2013. Cases were identified by searching the electronic database 22 
(ViewPoint 5.6.8.428, ViewPoint Bildverarbeitung GmbH, Weßling, Germany) in the 23 
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Fetal Medicine Unit, St George’s Hospital. The inclusion criteria were singleton 1 
pregnancies in which the fetal biometry, including the AC, was recorded at 20-24 weeks’ 2 
gestation and at or beyond 35 weeks’ gestation, within two weeks of delivery. The 3 
primary outcome was the relationship between low CPR at term and reduced fetal 4 
growth velocity. The secondary outcome was the relationship between low CPR at term, 5 
reduced fetal growth velocity and adverse pregnancy outcome.  6 
 7 
Growth velocity was quantified using the difference in AC, based on gestational age-8 
specific Z score, comparing the scan at or beyond 35 weeks with the scan at 20-24 9 
weeks. We generated deciles by use of the distribution in the study cohort. We defined 10 
as abnormal the lowest decile of AC growth velocity. The lowest decile of the difference 11 
of Z score between the AC in the third trimester and the AC in the second trimester was 12 
-1.4408. This is very similar to the value (-1.4808) reported by Sovio et al.6 The umbilical 13 
artery and middle cerebral artery Dopplers were also recorded at the same visit at or 14 
beyond 35 weeks’ gestation. In our unit, umbilical artery and middle cerebral artery 15 
Dopplers are routinely recorded at all ultrasound scans in the third trimester. The 16 
indications for the ultrasound assessment performed in the third trimester included 17 
suspected poor/excessive fetal growth, reduced fetal movements, history of SGA or 18 
large for gestational age baby, high mid-trimester uterine artery Doppler indices or 19 
gestational diabetes. These pregnancies were therefore at risk of fetal growth disorders. 20 
Pregnancies complicated by fetal abnormality, aneuploidy or genetic syndrome, and 21 
those with missing pregnancy outcome data, were excluded from the analysis.  22 
 23 
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Gestational age was calculated from the crown-rump length measurement at 11-13 1 
weeks’ gestation and only the last examination was included in the analysis.21,22 Routine 2 
fetal biometry was performed according to a standard protocol and the estimated fetal 3 
weight calculated.23 The umbilical artery and middle cerebral artery Doppler waveforms 4 
were recorded using color Doppler, and the pulsatility index (PI) calculated according to 5 
a standard protocol.24,25 In brief, middle cerebral artery PI values were obtained in the 6 
space where the artery passes by the sphenoid wing close to the Circle of Willis, and 7 
umbilical artery PI values were obtained from one of the umbilical arteries in a free loop 8 
of umbilical cord. When three similar consecutive waveforms were obtained, the PI was 9 
measured. The measurements were obtained in the absence of fetal movement, and 10 
keeping the insonation angle with the examined vessels at less than 30o. The CPR was 11 
calculated as the simple ratio between the middle cerebral artery PI and the umbilical 12 
artery PI.26 The CPR values were not available to the clinicians as the values were 13 
calculated as part of the data analysis for this study. All Doppler indices were converted 14 
into multiples of median (MoM), correcting for gestational age using reference ranges 15 
(27, umbilical and middle cerebral 28), and birthweight values were converted into 16 
centiles.29 When individuals had more than one ultrasound with Doppler values during 17 
the pregnancy, the last one before delivery was used in the analysis.   18 
The study cohort was divided into four groups according to a combination of a birth 19 
weight cut-off of the 10th centile (SGA) and a CPR cut-off of 0.6765 MoM (the 5th centile 20 
of the group with birthweight above the 90th centile [Large for Gestational Age] which is 21 
least likely to present with failure to reach growth potential). This was to assess the 22 
difference between the SGA model, which relies on fetal biometry, and the failure to 23 
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reach growth potential/placental insufficiency model, which relies on fetal hemodynamic 1 
assessment.127 Therefore the groups are: 1) SGA, low CPR, 2) SGA, normal CPR, 3) 2 
Appropriate for Gestational Age (AGA), low CPR and 4) AGA, normal CPR.  3 
 4 
Intrapartum data included whether the labor was induced or spontaneous, presence or 5 
absence of meconium stained liquor (grade 2 or 3), cardiotocograph abnormalities 6 
(classified according to National Institute for Health and Care Excellence guidelines),30 7 
ST analysis abnormalities,31 use of oxytocin for slow progress of labor, intrapartum 8 
pyrexia, intrapartum hemorrhage, use of epidural analgesia for labor, and mode of 9 
delivery. Data on maternal baseline characteristics and pregnancy outcomes were 10 
collected from hospital obstetric and neonatal records. The two adverse pregnancy 11 
outcomes examined in this study were operative delivery for presumed fetal 12 
compromise and admission to the neonatal unit. The neonatal morbidity is the subject of 13 
another study. Operative delivery included both cesarean section and instrumental 14 
delivery. The diagnosis of fetal compromise was based on cardiotocograph 15 
abnormalities, ST analysis abnormalities, abnormal fetal scalp blood sample pH or a 16 
combination of these. Pregnancies which had an elective cesarean section were 17 
excluded from the analysis for this outcome. The study was exempted from review by 18 
Wandsworth Research Ethics Committee. Some of the pregnancies reported in this 19 
study were included in a previous study.19 20 
 21 
Statistical Analysis  22 
 23 
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Data are presented as median and interquartile ranges (IQR) for continuous data and 1 
as n (%) for categorical variables. Categorical variables were compared by X2-test or 2 
Fisher’s exact test, while continuous data were compared using Mann-Whitney U-test. 3 
Comparison among the 4 study groups was performed using the Mann-Whitney test 4 
with post-hoc Bonferroni correction for multiple comparisons (p<0.025). Univariable and 5 
multivariable logistic regression analyses were performed to assess the relationship 6 
between low CPR MoM and AC growth velocity in the lowest decile. Logistic regression 7 
models were constructed for the two clinical outcomes included in this study: operative 8 
delivery for fetal compromise and admission to the neonatal unit. The variables included 9 
were maternal age, body mass index, parity, ethnicity, smoking, history of drug abuse, 10 
the AC growth velocity in the lowest decile, low CPR MoM, umbilical artery PI, middle 11 
cerebral artery PI, gestational age at delivery, SGA, induction of labor, use of epidural 12 
analgesia in labor, intrapartum pyrexia, intrapartum hemorrhage, presence of meconium 13 
grade 2 or 3, and the use of oxytocin for slow progress. As a sensitivity analysis, we 14 
refitted the model excluding the data on pregnancies with SGA neonates. We also 15 
investigated the antenatal risk factors separately from the intrapartum risk factors; 16 
although the latter potentially influence the two clinical outcomes investigated in this 17 
study, they are not available during the pregnancy and therefore are not considered 18 
during antenatal management. Both unadjusted and adjusted odds ratios (OR) were 19 
calculated. All p values were two-tailed; p values <0.05 were considered statistically 20 
significant. 21 
 22 
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The analysis was performed using the statistical software packages SPSS 18.0 (SPSS 1 
Inc., Chicago, IL, USA), Stata 11 (release 11.2. College Station, Texas, USA) and 2 
GraphPad Prism® 5.0 for Windows (InStat, GraphPad Software Inc., San Diego, 3 
California, USA). 4 
 5 
RESULTS 6 
We included 7944 pregnancies in the analysis. The maternal demographics, including 7 
age, body mass index, parity, ethnicity, smoking and drug use are shown in Table 1. 8 
The prevalence of SGA in this cohort was 14.5%. The overall operative delivery rate for 9 
presumed fetal compromise was 15.6%, while the neonatal unit admission rate was 10 
3.7%. The ultrasound parameters and pregnancy outcome data are also shown in Table 11 
1. The median (IQR) interval between the second and third trimester ultrasound scans 12 
was 18.4 (16.6-19.6) weeks. The median (IQR) gestational age at delivery was 41.1 13 
(39.4-41.9) weeks and the interval between the third trimester ultrasound scan and 14 
delivery was 0.6 (0.3-1.0) weeks. 15 
 16 
There was a significant positive association between the AC growth velocity and both 17 
the birthweight centile (R2=0.09, p<0.001) and the CPR MoM (R2=0.02, p<0.001). 18 
Reduced AC growth velocity (in the lowest decile) was significantly associated with 19 
umbilical artery PI MoM (OR 3.54; 95%CI 2.49-5.03, p<0.001), middle cerebral artery PI 20 
MoM (OR 0.43, 95%CI 0.33-0.57, p<0.001), CPR MoM (OR 0.28, 95%CI 0.21-0.38, 21 
p<0.001), birthweight centile (OR 0.98, 95%CI 0.978-0.983, p<0.001) and SGA (OR 22 
2.65, 95%CI 2.24-3.14, p<0.001). The results of the multivariable logistic regression 23 
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analysis demonstrated that low CPR MoM was significantly associated with both 1 
reduced AC growth velocity (adjusted OR 2.10; 95%CI 1.71-2.57, p<0.001) and SGA 2 
(adjusted OR 3.60; 95%CI 3.04-4.25, p<0.001). After the exclusion of pregnancies 3 
resulting in SGA neonates, reduced AC growth velocity was significantly associated with 4 
the umbilical artery PI MoM (OR 2.35; 95%CI 1.49-3.69, p<0.001), middle cerebral 5 
artery PI MoM (OR 0.69, 95%CI 0.51-0.93, p=0.017), CPR MoM (OR 0.47, 95%CI 0.33-6 
0.65, p<0.001) and birthweight centile (OR 0.98, 95%CI 0.979-0.986, p<0.001). Low 7 
CPR MoM remained significantly associated with both reduced AC growth velocity 8 
(adjusted OR 1.76; 95%CI 1.34-2.30, p<0.001) and birthweight centile (adjusted OR 9 
0.99; 95%CI 0.998-0.995, p<0.001).  10 
 11 
The prevalence of reduced AC growth velocity (in the lowest decile) in the 4 study 12 
groups according to the fetal size (SGA or not) and the CPR MoM is shown in Figure 1. 13 
Reduced AC growth velocity was most common (31%) in group 1 (SGA, low CPR), 14 
when compared to the remaining 3 groups (p<0.001 for all). Reduced AC growth 15 
velocity was more common in group 3 (AGA, low CPR) than in group 4 (AGA, normal 16 
CPR) (14.3% vs 7.9%, p<0.001). A comparison of the AC growth velocity among the 4 17 
study groups according to the fetal size (SGA or not) and the CPR MoM is shown in 18 
Figure 2. The AC growth velocity was significantly lower in group 1 (SGA, low CPR) 19 
when compared to the remaining 3 groups (p<0.001 for all). The AC growth velocity was 20 
significantly lower in group 3 (AGA, low CPR) than in group 4 (AGA, normal CPR) 21 
(median -0.15 and IQR -0.94, 0.66 vs median 0.12 and IQR -0.63, 0.84, p<0.001).  22 
 23 
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The need for operative delivery for presumed fetal compromise was significantly 1 
associated with low CPR (adjusted OR 1.40; 95%CI 1.10-1.78, p=0.006), even after 2 
adjusting for both the umbilical artery PI MoM and middle cerebral artery PI MoM. The 3 
results were similar even after the exclusion of pregnancies resulting in SGA neonates; 4 
in this subset, after adjusting for both the umbilical artery PI MoM and middle cerebral 5 
artery PI MoM, the need for operative delivery for presumed fetal compromise remained 6 
significantly associated with low CPR (adjusted OR 1.39; 95%CI 1.06-1.84, p=0.018).  7 
The results of the univariable logistic regression analysis for operative delivery for 8 
presumed fetal compromise are shown in Table 2. Low CPR MoM (p<0.001), umbilical 9 
artery PI (p=0.016), but not the middle cerebral artery PI (p=0.195), reduced AC growth 10 
velocity (p=0.087) or SGA (p=0.395), were significantly associated with the risk of 11 
operative delivery for presumed fetal compromise. The results of the multivariable 12 
logistic regression analysis for operative delivery for presumed fetal compromise are 13 
shown in Table 3.  Low CPR MoM remained significantly associated with the risk of 14 
operative delivery for presumed fetal compromise (p=0.023), even after adjusting for the 15 
known risk factors, fetal size and reduced AC growth velocity. These associations 16 
persisted even after exclusion of SGA cases from the cohort (Tables 2 and 3). Low CPR 17 
MoM (p<0.001), umbilical artery PI (p=0.015), reduced AC growth velocity (p=0.022), 18 
but not the middle cerebral artery PI (p=0.107), were significantly associated with the 19 
risk of operative delivery for presumed fetal compromise. Low CPR MoM remained 20 
significantly associated with the risk of operative delivery for presumed fetal 21 
compromise (p=0.026), even after adjusting for the known risk factors and reduced AC 22 
growth velocity. 23 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
19 
 
When the logistic regression analysis was limited to the antenatal risk factors only, low 1 
CPR MoM (adjusted OR 1.26; 95%CI 1.02-1.57, p=0.033), SGA (adjusted OR 1.44; 2 
95%CI 1.17-1.77, p=0.001), maternal age (adjusted OR 1.05; 95%CI 1.03-1.06, 3 
p<0.001), gestational age at delivery (adjusted OR 1.32; 95%CI 1.25-1.40, p<0.001), 4 
multiparity (adjusted OR 0.23; 95%CI 0.19-0.27, p<0.001), maternal body mass index 5 
(adjusted OR 1.02; 95%CI 1.00-1.03, p=0.028) and ethnicity (adjusted OR 1.10; 95%CI 6 
1.03-1.17, p=0.005), but not reduced AC growth velocity (p=0.289), smoking (p=0.739) 7 
and drug abuse (p=0.551), were significantly associated with the risk of operative 8 
delivery for presumed fetal compromise.  9 
 10 
The results of the univariable and multivariable logistic regression analyses for neonatal 11 
unit admission are shown in Table 4. The univariable regression analysis demonstrated 12 
that both low CPR MoM (p=0.001), umbilical artery PI (p=0.001), middle cerebral artery 13 
PI (p=0.025) and SGA (p=0.024), but not reduced AC growth velocity (p=0.752), were 14 
significantly associated with the risk of neonatal unit admission. Using multivariable 15 
logistic regression, both low CPR MoM and SGA were no longer significantly associated 16 
with the risk of neonatal unit admission (p>0.05). The only antenatal variable which 17 
remained significantly associated with the risk of neonatal unit admission was the 18 
umbilical artery PI (adjusted OR 2.33, 95% CI 1.05-5.20, p=0.039). 19 
 20 
When the logistic regression analysis was limited to the antenatal risk factors only, low 21 
CPR MoM (adjusted OR 1.61; 95%CI 1.12-2.32, p=0.010), multiparity (adjusted OR 22 
0.63; 95%CI 0.47-0.83, p=0.001) and maternal body mass index (adjusted OR 1.03; 23 
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95%CI 1.01-1.05, p=0.010) were significantly associated with the risk of neonatal unit 1 
admission. However, reduced AC growth velocity (p=0.632), SGA (p=0.374), gestational 2 
age at delivery (p=0.713), maternal age (p=0.528), ethnicity (p=0.411), smoking 3 
(p=0.517) and drug abuse (p=0.622) were not significantly associated with the risk of 4 
neonatal unit admission.  5 
 6 
 7 
DISCUSSION 8 
 9 
Main Findings 10 
The results of this study demonstrate that low CPR – a functional marker of fetal 11 
hypoxemia and cerebral redistribution - is significantly associated with impaired fetal AC 12 
growth velocity, a biometric marker of failure to reach growth potential, even in fetuses 13 
which are considered to be of appropriate size (≥ the 10th percentile). The AC growth 14 
velocity in the lowest decile is significantly associated with being SGA, low CPR MoM 15 
and operative delivery for presumed fetal compromise, but not the risk of neonatal unit 16 
admission. Low CPR MoM was significantly and independently associated with the risk 17 
of operative delivery for presumed fetal compromise, while SGA was not. Both low CPR 18 
and SGA were significantly associated with the risk of admission to the neonatal unit, 19 
when tested in univariable logistic regression and multivariable logistic regression 20 
models adjusting for antenatal risk factors, but not when adjusting for both antenatal 21 
and intrapartum risk factors. 22 
 23 
Interpretation of the findings and comparison with existing literature 24 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
21 
 
The findings of this study are consistent with existing literature and our previous 1 
findings.6,18,19,31 Recent studies have demonstrated that low CPR is significantly 2 
associated with adverse pregnancy outcomes, including operative delivery for 3 
presumed fetal compromise, neonatal unit admission, stillbirth and neonatal 4 
morbidity.18,19,32-34  5 
The role of CPR as a marker of failure to reach growth potential has recently gained 6 
interest among researchers and clinicians.19,20,35,36 This study therefore represents a 7 
useful addition to the literature investigating the role of CPR as a measure of cerebral 8 
redistribution or brain sparing. Most studies have focused on small fetuses, reporting a 9 
promising role for CPR in identifying SGA fetuses at risk of adverse outcomes. In a 10 
recent meta-analysis, low CPR was associated with an increased risk of cesarean 11 
section for fetal distress (OR 4.49; 95% CI 1.63-12.42), low APGAR score (OR 4.01; 12 
95% CI 2.65-6.08), neonatal unit admission (OR 9.65; 95% CI 3.02-30.85) and neonatal 13 
complications (OR 11.00; 95% CI 3.64-15.37).35 The findings of the PORTO study have 14 
reiterated the significant role of the CPR in identifying fetuses at risk.34 Small fetuses 15 
with abnormal CPR had an 11-fold increased risk of adverse pregnancy outcome, in 16 
particular neonatal morbidity, when compared to those with normal CPR.34   17 
 18 
We recently reported that the CPR is a marker of failure to reach growth potential and 19 
adverse pregnancy outcomes, even in fetuses that are not considered at risk using 20 
current standards.19,20 The role of the CPR in the assessment of fetal wellbeing in both 21 
SGA and AGA fetuses was appraised in a recent review.36 The fact that CPR is a 22 
marker of impaired fetal growth velocity, even in AGA fetuses, and that it is associated 23 
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with adverse pregnancy outcome questions the current guidelines that have ignored the 1 
potential value of assessment of the fetal Doppler in AGA fetuses, simply because the 2 
estimated fetal weight is above the 10th centile.37,38 Identification of the at-risk fetus at 3 
term is challenging, while its management is usually easy (delivery). Our finding of a 4 
potential additive value of the CPR, above and beyond its components (umbilical artery 5 
and middle cerebral artery Doppler), is consistent with the data from prospective 6 
studies.32,39 Despite the fact that this study focused on the role of abnormal CPR near 7 
term, previous studies have demonstrated its potential value in early-onset FGR, in 8 
particular its association with a higher risk of perinatal death, higher rate of Cesarean 9 
delivery for fetal distress in labour, higher rate of Apgar scores less than 7 at 5 minutes, 10 
an increased rate of neonatal acidosis, and an increased rate of neonatal unit 11 
admission.40-45The role of impaired fetal growth in identifying fetuses at risk of neonatal 12 
morbidity has been demonstrated in a screening study involving 4512 nulliparous 13 
women recruited over 4 years in Cambridge, UK.5 An estimated fetal weight below the 14 
10th centile was associated with the risk of neonatal morbidity only if the fetal AC growth 15 
velocity was in the lowest decile.6 These findings reinforce the importance of including 16 
assessment tools, other than simply estimated fetal weight less than the 10th centile, to 17 
identify those fetuses at risk of adverse outcome. Of note, this study did not report data 18 
on the fetal CPR or middle cerebral artery Doppler.6 In fact, the association between 19 
fetal growth and adverse pregnancy outcome was previously reported in the older 20 
literature, where the fetal growth rate was significantly lower in pregnancies with 21 
operative delivery for presumed fetal distress (20.9 g/day) or neonatal unit admission 22 
(20.3 g/d) compared to those with uncomplicated outcome (21.9 g/day).7 In contrast, our 23 
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study found no significant association between reduced AC growth velocity and 1 
neonatal unit admission. This difference could be explained by the different tool used to 2 
assess fetal growth velocity. In the study by de Jong et al,7 the fetal weight gain in the 3 
third trimester was modeled using a minimum of five time points to derive a fetal weight 4 
curve for each pregnancy: a fixed second trimester point, representing Hadlock’s mean 5 
value for fetal weight at 18 weeks, three or more third-trimester fetal weight estimates 6 
and the birthweight.7 In our study we quantified the growth velocity using the difference 7 
in AC, based on gestational age-specific Z score, comparing the scan at or beyond 35 8 
weeks with the scan at 20-24 weeks. We defined as abnormal the lowest decile of AC 9 
growth velocity. In the study by Regan et al, the growth rate was estimated by 10 
subtracting the index estimated fetal weight from the subsequent estimated fetal weight 11 
and dividing the value by the number of days between the sonographic examinations, in 12 
order to obtain an estimate of the growth rate in grams per day.18 However, this 13 
assumes a uniform growth rate throughout that interval, which might not be true.  14 
Clinical and research implications 15 
There is no consensus regarding what constitutes normal or abnormal fetal growth, but 16 
the AC interval growth is one of the commonest parameters used in the clinical setting. 17 
It is important, though, to take into account the fact that interval growth assessment 18 
might be susceptible to inaccuracies in biometric measurements as a result of intra- and 19 
inter-observer variability.46 This is most likely when the time interval between 20 
examinations is short. In our study, the median interval between the second and third 21 
trimester scans was 18 weeks. Recently, a consensus definition for placental fetal 22 
growth restriction was reached using a Delphi procedure: late fetal growth restriction 23 
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(beyond 32 weeks) was defined using four parameters: estimated fetal weight 1 
<10th percentile, AC <10th percentile, crossing centiles on growth charts of more than 2 
two quartiles, and CPR <5th percentile.47 Even when corrected for fetal growth velocity, 3 
low CPR remains significantly associated with the risk of operative delivery for 4 
presumed fetal compromise. This suggests that CPR is a potentially useful tool for the 5 
identification of at risk fetuses.  6 
 7 
Despite the promising potential role of fetal growth and Dopplers in improving the 8 
identification of fetuses at risk of adverse outcome, the extent to which these 9 
parameters could be used to predict perinatal morbidity and guide the mode of delivery 10 
merits further investigation. These studies should ascertain the gestational age at 11 
assessment, CPR cut-off at which to diagnose fetal compromise, long-term (not just 12 
short-term) morbidity, and which interventions could potentially improve the perinatal 13 
outcome. Furthermore, as reported by Sovio et al, the improvement in the detection of 14 
SGA neonates using assessment of the fetal growth was associated with an increase in 15 
the false positive rate (two false positive diagnoses for every additional SGA neonate 16 
detected), and therefore, additional parameters such as the CPR or biochemical 17 
markers might be required to optimize the predictive accuracy for the identification of 18 
the fetus at risk.6,48 19 
 20 
Study strengths and limitations 21 
The strengths of our study include the large number of pregnancies, the short interval 22 
between third trimester ultrasound and delivery, ascertainment of the outcome data and 23 
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adjusting for possible confounding variables including maternal demographics and 1 
intrapartum risk factors. Furthermore, neither the difference in AC Z scores nor the CPR 2 
values were calculated until the analysis for this study. Therefore, the healthcare 3 
professionals providing the intrapartum care were effectively blinded to these values. 4 
The retrospective design is a limitation and the data could be biased by selective 5 
assessment of a population referred for ultrasound scan in the third trimester, which is 6 
not routine practice in the UK. This could explain the higher than expected proportion of 7 
SGA in the study cohort. This is mitigated by the relatively large dataset of prospectively 8 
collected data and because the majority of women delivered at term and had normal 9 
birthweight babies. However, we see this as a strength whereby, despite the bias 10 
towards lower birthweight and higher prevalence of SGA, reduced AC growth velocity 11 
and low CPR were independently associated with the risk of operative delivery for 12 
presumed fetal compromise, and low CPR was also associated with the risk of neonatal 13 
unit admission. Another potential limitation is the fact that the results of the ultrasound 14 
and Doppler assessment were not blinded, giving rise to the possibility that this 15 
knowledge could have influenced subsequent clinical intervention and a ‘treatment 16 
effect’. However, during the study period, intervention in the form of induction of labor 17 
was undertaken only for estimated fetal weight less than the 5th centile or umbilical 18 
artery PI above the 95th centile, as per local protocol. Hence, these interventions should 19 
be relatively un-influenced by reduced AC growth velocity or low CPR. The study cohort 20 
was scanned by a large number of different operators, raising the possibility of inter-21 
observer variability in the measurements.  The threshold for the diagnosis of fetal 22 
compromise is also likely to have been influenced by changing personnel and attitudes 23 
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towards intrapartum management over the 14 year period. Finally, as this was a single 1 
center study, there is a potential for selection bias, which might compromise 2 
generalizability. 3 
Conclusion 4 
The findings of this study demonstrate that CPR is a marker of impaired fetal AC growth 5 
velocity and adverse pregnancy outcome, even in fetuses whose size is considered 6 
AGA using conventional biometry.  7 
8 
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Table 1. Maternal demographics, ultrasound parameters and pregnancy outcomes of the study population.  
 
Variable Values 
Maternal demographics 
  
Maternal age in years, median (IQR) 31.0 (27.0-35.0) 
Body mass index in kg/m2, median (IQR) 24.0 (21.6-27.5) 
Nulliparous, n (%) 4419 (55.6) 
Maternal ethnicity   
  Caucasian, n (%) 4974 (62.6) 
  Afro-Caribbean, n (%) 1257 (15.8) 
  South Asian, n (%) 1301 (16.4) 
  East Asian, n (%) 88 (1.1) 
  Mixed, n (%) 262 (3.3) 
  Other, n (%) 62 (0.8) 
Smoking, n (%) 478 (6.0) 
Drug abuse, n (%) 44 (0.6) 
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Ultrasound parameters 
  
Gestational age at the second trimester ultrasound in weeks, median (IQR) 21.9 (21.4-22.3) 
Abdominal circumference in mm at 20-24 weeks' gestation, median (IQR) 
166.7 (160.2-
174.4) 
Abdominal circumference Z score at 20-24 weeks' gestation, median (IQR) 0.02 (-0.75-0.72) 
Gestational age at the third trimester ultrasound in weeks, median (IQR) 40.4 (38.4-41.4) 
Abdominal circumference in mm in third trimester, median (IQR) 
344.0 (326.6-
361.3) 
Abdominal circumference Z score in third trimester, median (IQR) -0.02 (-0.69-0.67) 
Estimated fetal weight at the third trimester scan in grams, median (IQR) 3492 (3047-3871) 
Umbilical artery pulsatility index (PI), median (IQR)  0.82 (0.71-0.93) 
Umbilical artery PI multiple of median (MoM), median (IQR)  1.00 (0.88-1.13) 
Middle cerebral artery PI, median (IQR)  1.31 (1.12-1.54) 
Middle cerebral artery PI MoM, median (IQR)  1.30 (1.13-1.50) 
Cerebroplacental ratio, median (IQR) 1.62 (1.35-1.95) 
Cerebroplacental ratio MoM, median (IQR) 0.96 (0.80-1.15) 
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Interval between the second and third trimester ultrasound scans in weeks, 
median (IQR) 18.4 (16.6-19.6) 
Abdominal circumference growth velocity, median (IQR) 0.01 (-0.74-0.74) 
Abdominal circumference growth velocity in the lowest decile, n (%) 795 (10) 
Intrapartum factors 
  
Induction of labor, n (%) 2798 (35.2) 
Epidural use, n (%) 2966 (37.3) 
Intrapartum pyrexia, n (%) 172 (2.2) 
Intrapartum hemorrhage, n (%) 21 (0.3) 
Oxytocin used for slow progress, n (%) 2022 (25.5) 
Meconium grade 2/3, n (%) 183 (2.3) 
Pregnancy outcome 
  
Birthweight in grams, median (IQR) 3435 (3050-3800) 
Birthweight centile, median (IQR) 
45.33 (19.28-
74.43) 
Small for gestational age, n (%) 1151 (14.5) 
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Stillbirth, n (%) 15 (0.2) 
Gestational age at delivery in weeks, median (IQR) 41.1 (39.4-41.9) 
Interval between the ultrasound and delivery in weeks, median (IQR) 0.6 (0.3-1.0) 
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Table 2. Results of the univariable logistic regression analysis of variables associated with the need for operative delivery 
for presumed fetal compromise. 
Risk factors Total study population 
Study population excluding 
pregnancies resulting in a small for 
gestational age neonate 
  
Unadjusted 
OR 95% CI P-value 
Unadjusted 
OR 95% CI P-value 
Maternal age (years) 1.02 1.01-1.03 <0.001 1.02 1.01-1.03 <0.001 
Body mass index (kg/m2) 1.00 0.98-1.01 0.452 0.99 0.98-1.01 0.381 
Multiparous 0.25 0.21-0.29 <0.001 0.24 0.21-0.29 <0.001 
Ethnicity 0.93 0.88-0.99 0.020 0.92 0.86-0.98 0.012 
Smoking 0.65 0.49-0.87 0.004 0.72 0.52-1.00 0.047 
Drug abuse 0.62 0.24-1.57 0.313 0.47 0.14-1.54 0.215 
Abdominal circumference growth 
velocity in the lowest decile 1.19 0.98-1.44 0.087 1.30 1.04-1.62 0.022 
Low cerebroplacental ratio MoM 1.45 1.20-1.76 <0.001 1.54 1.22-1.93 <0.001 
Umbilical artery PI MoM 1.46 1.08-2.00 0.016 1.56 1.09-2.24 0.015 
Middle cerebral artery PI MoM 0.87 0.70-1.07 0.195 0.83 0.66-1.04 0.107 
Gestational age at delivery (weeks) 1.36 1.29-1.43 <0.001 1.43 1.34-1.51 <0.001 
Small for gestational age 1.08 0.91-1.28 0.395 - - - 
Induction of labor 1.84 1.63-2.08 <0.001 1.84 1.61-2.12 <0.001 
Epidural use 5.93 5.15-6.83 <0.001 6.23 5.35-7.32 <0.001 
Intrapartum pyrexia 5.64 4.15-7.66 <0.001 5.60 4.08-7.69 <0.001 
Intrapartum hemorrhage 4.21 1.79-9.95 0.001 3.29 1.25-8.66 0.016 
Oxytocin used for slow progress 3.15 2.78-3.57 <0.001 3.30 2.88-3.78 <0.001 
Meconium grade 2/3 2.55 1.86-3.49 <0.001 2.56 1.82-3.60 <0.001 
MoM = multiples of median; pulsatility index = PI 
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Table 3.  Results of the multivariable logistic regression analysis of variables associated with the need for operative 
delivery for presumed fetal compromise. 
Risk factors Total study population 
Study population excluding 
pregnancies resulting in a small for 
gestational age neonate 
  
Unadjusted 
OR 95% CI P-value 
Unadjusted 
OR 95% CI P-value 
Maternal age (years) 1.04 1.02-1.05 <0.001 1.04 1.02-1.05 <0.001 
Body mass index (kg/m2) 1.01 0.99-1.02 0.440 1.01 0.99-1.02 0.455 
Multiparous 0.38 0.31-0.46 <0.001 0.38 0.31-0.47 <0.001 
Ethnicity 1.10 1.03-1.18 0.006 1.10 1.02-1.19 0.010 
Smoking 0.90 0.64-1.25 0.525 0.98 0.67-1.42 0.905 
Drug abuse 0.83 0.31-2.25 0.721 0.53 0.15-1.81 0.309 
Abdominal circumference growth 
velocity in the lowest decile 1.21 0.96-1.53 0.101 1.38 1.06-1.79 0.016 
Low cerebroplacental ratio MoM 1.30 1.04-1.64 0.023 1.36 1.04-1.77 0.026 
Gestational age at delivery (weeks) 1.20 1.13-1.28 <0.001 1.20 1.12-1.28 <0.001 
Small for gestational age 1.58 1.27-1.96 <0.001 - - - 
Induction of labor 1.22 1.05-1.42 0.008 1.23 1.05-1.45 0.012 
Epidural use 4.05 3.39-4.84 <0.001 4.08 3.35-4.98 <0.001 
Intrapartum pyrexia 2.62 1.85-3.70 <0.001 2.61 1.82-3.75 <0.001 
Intrapartum hemorrhage 7.33 2.52-21.32 <0.001 5.91 1.72-20.25 0.005 
Oxytocin used for slow progress 0.98 0.83-1.15 0.767 0.98 0.82-1.18 0.844 
Meconium grade 2/3 3.17 2.16-4.66 <0.001 2.84 1.87-4.31 <0.001 
MoM = multiples of median. Each variable included in the list of risk factors has been included in the multivariable logistic 
regression analysis.
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Table 4. Results of the univariable and multivariable logistic regression analysis of variables associated with admission to 
the neonatal unit. 
Risk factor Unadjusted OR 95% CI P-value 
Adjusted 
OR 95% CI P-value 
Maternal age (years) 0.98 0.96-1.00 0.052 0.98 0.96-1.01 0.201 
Body mass index (kg/m2) 1.02 1.00-1.05 0.048 1.03 1.00-1.05 0.051 
Multiparous 0.64 0.50-0.81 <0.001 0.83 0.59-1.17 0.279 
Ethnicity 1.04 0.94-1.15 0.463 1.06 0.93-1.20 0.370 
Smoking 1.28 0.82-2.00 0.278 1.19 0.64-1.96 0.694 
Drug abuse 0.60 0.08-4.39 0.617 0.67 0.09-5.00 0.697 
Abdominal circumference growth 
velocity in the lowest decile 1.06 0.73-1.55 0.752 0.67 0.40-1.15 0.147 
Low cerebroplacental ratio MoM 1.71 1.23-2.38 0.001 0.85 0.49-1.47 0.554 
Umbilical artery PI MoM 2.46 1.42-4.29 0.001 2.33 1.05-5.20 0.039 
Middle cerebral artery PI MoM 0.62 0.40-0.94 0.025 0.66 0.37-1.18 0.159 
Gestational age at delivery (weeks) 0.96 0.89-1.03 0.233 0.99 0.89-1.10 0.814 
Small for gestational age 1.41 1.05-1.90 0.024 1.23 0.82-1.85 0.312 
Induction of labor 1.10 0.86-1.40 0.467 1.07 0.80-1.43 0.656 
Epidural use 1.99 1.54-2.57 <0.001 1.56 1.11-2.20 0.011 
Intrapartum pyrexia 6.14 4.03-9.36 <0.001 4.45 2.73-7.26 <0.001 
Intrapartum hemorrhage 4.56 1.34-15.60 0.015 4.47 1.00-19.93 0.050 
Oxytocin used for slow progress 1.54 1.20-1.96 0.001 1.04 0.74-1.47 0.804 
Meconium grade 2/3 5.03 3.31-7.64 <0.001 4.63 2.79-7.68 <0.001 
MoM = multiples of median; pulsatility index = PI 
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FIGURE LEGENDS  
Figure 1.  The proportion of pregnancies with abdominal circumference growth velocity 
in the lowest decile in the four study groups according to a combination of a birthweight 
cut-off of the 10th centile and a cerebroplacental ratio (CPR) cut-off of 0.6568 MoM. 
(SGA = small for gestational age; AGA = appropriate for gestational age). 
 
Figure 2. Box and whisker plots of the abdominal circumference (AC) growth velocity in 
the four study groups according to a combination of a birthweight cut-off of the 10th 
centile and a cerebroplacental ratio (CPR) cut-off of 0.6568 MoM. (SGA = small for 
gestational age; AGA = appropriate for gestational age). The horizontal line in the box 
represents the median, the box represents the interquartile range and the whiskers 
indicate the minimum and maximum values. 
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